MSI-H/dMMR Gastric Cancer
Oncology·MeSH: Neoplasm Metastasis
Prevalence
10.0 / 100K
Incidence
6.1 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target MSI-H/dMMR Gastric Cancer?
There are 2 clinical trials targeting MSI-H/dMMR Gastric Cancer tracked by BioSniper.
What is the prevalence of MSI-H/dMMR Gastric Cancer?
The estimated prevalence of MSI-H/dMMR Gastric Cancer is approximately 10.0 per 100,000 population.
Deep-dive into MSI-H/dMMR Gastric Cancer
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis